Lenacapavir
Drug Details
- Generic Name
- Lenacapavir
- Brand Names
- N/A
- Application Number
- Sponsor
- HETERO LABS LIMITED
- NDC Codes
- 2
- Dosage Forms
- POWDER
- Routes
- N/A
- Active Ingredients
- LENACAPAVIR SODIUM, LENACAPAVIR
Indications and Usage
1 INDICATIONS AND USAGE SUNLENCA, in combination with other antiretroviral(s), is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily treatment-experienced adults with multidrug resistant HIV-1 whose current antiretroviral regimen is failing due to resistance, intolerance, or safety considerations. SUNLENCA, a human immunodeficiency virus type 1 (HIV-1) capsid inhibitor, in combination with other antiretroviral(s), is indicated for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug resistant HIV-1 whose current antiretroviral regimen is failing due to resistance, intolerance, or safety considerations. ( 1 )